Chris Peritore-Galve @fcperitore.bsky.social · 26/02/2026The first instrument of the Peritore lab arrived today! Shout out to @cytiva.bsky.social for the matching AKTA lego 🫡🧫🦠🧪 020
Chris Peritore-Galve @fcperitore.bsky.social · 07/11/202515/20 The lack of outward signs of disease and limited histopathology was curious, so we tested this with additional TcdB3+ strains and found that the mild disease with edema + inflammation being the most informative markers was consistent across ribotype 017 strains. 100
Chris Peritore-Galve @fcperitore.bsky.social · 07/11/202514/20 Mice infected with the TcdB3+ strain develop no appreciable epithelial damage, but they do exhibit high amounts of inflammation and edema. Surprisingly, even though AZD5148 did not neutralize TcdB3 in vitro, it significantly protected against the inflammation and edema phenotypes in vivo! 100
Chris Peritore-Galve @fcperitore.bsky.social · 07/11/202511/20 What is baffling is that despite protecting against lethality and weight loss, mAb therapy did not have an impact on pathology. This could be due to systemic effects of neutralizing TcdB, or the prevention of further damage by directing more AZD5148 from the bloodstream to the tissue, or more. 100